Respiratory syncytial virus (RSV) infects most children in the first year of life and is a major single cause of hospitalization in infants and young children. There is no effective vaccine, and antibody generated by primary neonatal infection is poorly protective against re-infection even with antigenically homologous viral strains.
Abstract
Respiratory syncytial virus (RSV) infects most children in the first year of life and is a major single cause of hospitalization in infants and young children. There is no effective vaccine, and antibody generated by primary neonatal infection is poorly protective against re-infection even with antigenically homologous viral strains.
Studying the immunological basis of these observations in neonatal mice, we found that antibody responses to infection were low and unaffected by CD4 depletion, in contrast with adult mice, which had stronger CD4 dependent antibody responses. NK cell depletion or co-depletion of CD4 
Introduction
Antibody responses to vaccines are poor in infancy (1) and this can lead to increased infection severity and decreased vaccination efficacy. It is believed that the paucity of the infantile antibody response is caused by immaturity of the cells involved (2, 3) .
Neonatal B cells are immature, expressing lower levels of MHC-II (4) and when B cells are transferred from adult mice into the footpads of neonates the antibody response is restored to adult levels (5) . In addition to poor B and T cell interactions, the development of follicular dendritic cells is delayed in both neonatal mice (6) and infants (7) . Improved understanding about B cell responses is required to improve early life vaccine strategies, particularly in the control of respiratory infections, which are a major cause of morbidity and mortality in infancy.
Respiratory syncytial virus (RSV) is the principal cause of viral lung infection in infants (8) . Hospitalization rates due to RSV bronchiolitis in the USA are 17 per 1,000 children below 6 months of age (9) , with an estimated 33.8 million cases of RSV associated lower respiratory tract infection and 66,000-199,000 deaths globally per annum (10) . Re-infection is common and does not necessarily depend on antigenic changes (11) , 47% of children infected in the first year of life are re-infected in their second year of life (12) . An effective RSV vaccine would be a major breakthrough in child health and since most children with RSV bronchiolitis are under 6 months of age, it would need to be effective in infancy. A core component of protection against RSV infection is antibody -high-titer, maternally-derived, RSV-neutralizing antibody is protective against hospitalization (13) and protection against re-infection in humans is associated with high titers of antibody (14) . Antibody responses seen in infants after both RSV infection (15, 16) and vaccination (17, 18) are weak, an effect usually attributed to reduced T cell help. Few CD4 T cell lymphocytes are found in the lungs of RSV infected infants (19) and the V gene repertoire for anti-RSV antibody is restricted in neonatal humans (20) . We have developed a mouse model of neonatal RSV infection (21) where we observed that infection of neonatal mice led to a T cell response that caused disease on subsequent re-infection (22). Furthermore, we subsequently showed that this pathogenic cellular response is dependent upon the mouse MHC haplotype (23).
Antibody titers are lower following experimental neonatal mouse RSV infection compared to adult infection (24). Studying the basis of these observations, we wished to assess whether the cellular response to neonatal RSV affected the antibody titer.
We found that CD4 
Results

Reduced antibody response in neonates compared to adults after RSV infection.
BALB/c mice were infected with 4x10 Figure 1A ). Mice infected as neonates had significantly lower viral loads than adults on day 4 post primary infection (Fig 1B, p<0 .01), as previously observed (21, 26) . Serum was collected 8 weeks after primary infection to allow maturation of responses. Sera from mice that had primary RSV infection as adults had significantly more RSV-specific ELISA binding (Fig 1C, p<0 .001) and neutralizing (Fig 1D, p<0.001) antibody than mice that had a primary infection as neonates. RSV-specific IgG subtypes were quantified by ELISA in sera. The neonatal RSV-IgG response was significantly skewed towards IgG1 (indicating a Th2 bias; p<0.001), whilst adult primary infection led to a balanced IgG1/IgG2a response (Fig S1A) .
Mice were re-infected with 10 6 PFU of the same RSV strain 8 weeks after their initial infection ( Fig 1A) . Previous exposure to RSV, regardless of age, significantly reduced viral load during secondary RSV infection, compared to primary RSV infection ( Fig   1B, p<0 .01). But mice that were primed as adults had a significantly reduced viral load than mice primed as neonates (p<0.05). Whilst re-infection significantly boosted antibody titers in both neonatally and adult primed mice (Fig 1C, p<0 .001), adult primed mice still had significantly greater antibody titers (Fig 1C, p<0 .001) and more potent neutralizing responses (Fig 1D, p<0 .001) than neonatally primed mice after reinfection. Adult re-infection of neonatally primed mice reversed the initial IgG1 bias, leading to a predominantly IgG2a response (Fig S1B) . Neonatal mice generated weaker antibody responses to RSV infection, which may reduce protection against subsequent viral re-exposure and contribute to the delayed sequelae of neonatal RSV infection (22).
T cells and NK cells inhibit the neonatal antibody response.
We have previously observed that depletion of T cells during neonatal RSV infection can have a protective effect during re-infection (22). To assess their effect on antibody responses, T cells were depleted during primary neonatal RSV infection and antibody responses measured before and after re-infection (schematic in Fig 1A) . Cell depletion significantly reduced the targeted cell type (Fig S2) . CD4 + cell depletion had no effect on the weak anti-RSV antibody response in neonates after primary (Fig 2A) or secondary infection (Fig 2B) . However, depletion of both CD4 (Fig 2C) but caused a significant reduction in anti-RSV IgG titer after re-infection (Fig 2D, p<0 .05), as previously observed (27). CD4 and CD8 co-depletion during primary adult RSV infection had no effect on IgG titer (Fig 2D) . To define the timing of the effect, T cells were depleted during secondary RSV infection of neonatally primed mice. When T cells were depleted during secondary RSV infection of neonatally primed mice, CD8 + cell depletion made no effect on antibody titer, but CD4 (Fig 2E, p<0.01 ). In addition, cell depletion during primary neonatal infection increased levels of IgG1 compared to control neonatal infection (Fig S1C-D) .
To test whether NK cells also affected the neonatal antibody response, we depleted NK cells with anti-asialo GM1 during primary neonatal RSV infection. NK cell depletion had no effect on antibody titer before re-infection (Fig 2F) . However, NK cell depleted neonatal mice had significantly higher anti-RSV IgG responses than untreated mice after re-infection (Fig 2G, p<0. mice are on a C57BL/6 background so we confirmed that cell depletion affected antibody levels in C57BL/6 mice ( Fig 2H) . Neonatal CD4 + cell depletion had no effect, but CD8 + cell depletion significantly increased RSV-specific antibody titer (p<0.05). When levels were compared, there was no significant difference in antibody titer between the wild type and FasL -/-deficient mice (Fig 2I) .
Interferon gamma inhibits the neonatal antibody response.
The lower viral load during primary neonatal infection may contribute to the reduced neonatal antibody responses. RSV viral titer was measured on day 4 after primary neonatal infection with and without cell depletion ( Fig 3A) . As previously demonstrated (30), NK depletion significantly increased viral load (p<0.05).
However, T cell depletion had no effect on viral load, suggesting that increased viral Fig 3G, p<0 .001). To determine whether cell depletion affected IFN-γ production, levels were measured in lung homogenates on day 4 after neonatal infection with and without cell depletion ( Fig   3H) . Reduced levels were seen in the anti-CD4 and CD8 double depletion group and the anti-NK group.
We next investigated whether IFN-γ might have an inhibitory effect on antibody responses. Neonatal mice were infected with RSV and IFN-γ was blocked using three doses of anti-IFN-γ (clone XMG1.2) i.p. on days -1, +2 and +5. Blocking IFN-γ during primary infection significantly boosted antibody prior to (Fig 4A, p<0 .05) and after (Fig 4B, p<0.001 ) re-infection. IFN-γ blockade lead to a more balanced IgG1:IgG2a ratio than control treatment (Fig S1E, p<0.05 ). To confirm that the IFN-γ was affecting the antibody response we used a recombinant RSV that expressed IFN-γ (33). As we have observed previously (31), there was no effect on antibody titer prior to rechallenge (Fig 4C) , but after rechallenge with wild type virus, the antibody response in the rRSV-IFN-γ primed animals was significantly lower than wild type RSV primed mice (Fig 4D, p<0 .001). Infection with rRSV-IFN-γ significantly reduced the IgG1 response (Fig S1F, However, multiple strands of evidence suggest that antibody titer is not solely influenced by viral load: depleting neonatal T cells had no effect on viral load ( Fig   3A) , anti-IFN-γ treatment decreased viral load (Fig 4E) , the rRSV-IFN-γ virus was significantly attenuated as previously observed (33, 42) and when neonatal or adult mice were infected with different amounts of virus, there was no effect on antibody response (Fig 3B, C) . The decrease in viral load after neonatal anti-IFN-γ treatment was in contrast to adult mice, which either had unchanged (43) RSV viral load was assessed by extracting RNA from lung tissue using STAT-60 or RNeasy mini kit (Qiagen) and then converting it into cDNA. Quantitative RT-PCR for the RSV L gene using primers and probes previously described, (21) was performed and the results normalized against 18s or GAPDH endogenous RNA levels. L gene copy number was determined using a RSV L gene standard and presented relative to μg lung RNA. 
